ScheBo Biotech AG

ScheBo Biotech AG (ScheBo) is a privately-held biotech company engaged in the design, development and marketing of diagnostic products in-vitro diagnostic products. It develops diagnostic tests for the gastroenterology, oncology, veterinary diagnostic and food and beverage markets. Its gastroenterology diagnostic tests are used for the quantification of human pancreatic elastase1. The company also develops tumor metabolic markers for detecting colorectal cancer and pyruvate kinase antibodies and tests for detecting BSE specified risk material in meat products. It is certified with ISO standards. ScheBo carries out its operations through its subsidiaries, ScheBo Biotech UK Ltd and ScheBo Biotech USA Inc in the UK and the US respectively. ScheBo is headquartered in Giessen, Germany.

Street: 
Netanyastrasse 3
City: 
Giessen
Postcode: 
35394
Federal State : 
Germany
WebSite: 
www.schebo.com
Fax: 
49-641-499677

Company Index Score

Current Index Score Historical Index Score
  • ScheBo Biotech AG currently scores 50 % in the index.
  • ScheBo Biotech AG is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • ScheBo Biotech AG is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets